FRM
Fox Run Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $581K | Buy |
+3,128
| New | +$581K | 0.1% | 401 |
|
|
2024
Q3 | – | Sell |
-2,477
| Closed | -$425K | – | 764 |
|
|
2024
Q2 | $425K | Buy |
+2,477
| New | +$425K | 0.08% | 468 |
|
|
2024
Q1 | – | Sell |
-4,025
| Closed | -$624K | – | 715 |
|
|
2023
Q4 | $624K | Buy |
4,025
+2,471
| +159% | +$383K | 0.16% | 218 |
|
|
2023
Q3 | $232K | Sell |
1,554
-4,681
| -75% | -$698K | 0.07% | 520 |
|
|
2023
Q2 | $840K | Buy |
+6,235
| New | +$840K | 0.24% | 128 |
|
|
2022
Q2 | – | Sell |
-2,137
| Closed | -$346K | – | 490 |
|
|
2022
Q1 | $346K | Buy |
+2,137
| New | +$346K | 0.19% | 214 |
|
|
2021
Q4 | – | Sell |
-3,603
| Closed | -$389K | – | 442 |
|
|
2021
Q3 | $389K | Buy |
+3,603
| New | +$389K | 0.25% | 146 |
|
|
2019
Q3 | – | Sell |
-5,030
| Closed | -$366K | – | 340 |
|
|
2019
Q2 | $366K | Buy |
+5,030
| New | +$366K | 0.24% | 155 |
|
|
2018
Q3 | – | Sell |
-9,734
| Closed | -$902K | – | 538 |
|
|
2018
Q2 | $902K | Buy |
9,734
+4,878
| +100% | +$452K | 0.29% | 51 |
|
|
2018
Q1 | $460K | Buy |
+4,856
| New | +$460K | 0.11% | 339 |
|
|
2017
Q2 | – | Sell |
-4,800
| Closed | -$313K | – | 609 |
|
|
2017
Q1 | $313K | Buy |
+4,800
| New | +$313K | 0.13% | 356 |
|
|
2016
Q3 | – | Sell |
-7,700
| Closed | -$477K | – | 467 |
|
|
2016
Q2 | $477K | Buy |
+7,700
| New | +$477K | 0.23% | 143 |
|
|
2016
Q1 | – | Sell |
-9,800
| Closed | -$581K | – | 394 |
|
|
2015
Q4 | $581K | Buy |
+9,800
| New | +$581K | 0.45% | 24 |
|